Simpulan SIMPULAN DAN SARAN
63 Complications
among NAFLD
Patients. World
Journal of
Gastroenterology.2013;198:1219-1229 26.
Chatrath H, Vuppalanchi R, Chalasani N. Dyslipidemia in Patients with Nonalcoholic Fatty Liver Disease. Semin Liv Dis.2012;321:22-29
27. McCance KL, Huether SE, Brashers SE, Rote NS. Pathophysiology the
Biologic Basis for Disease in Adults and Children. 6th ed. United States of America. Elsevier; 2010
28. Tortora GJ, Derrickson B. Principles of Anatomy Physiology. 13th ed.
United States of America. John Wiley Sons, Inc.; 2012 29.
Kamso S, Purwantyastuti, Juwita R. Dislipidemia Pada Lanjut Usia di Kota Padang. Makara Kesehatan.2002;62:55-58
30. Hatma RD. Lipid Profiles Among Diverse Ethnic Groups in Indonesia. Acta
Med Indones-Indones J Intern Med.2011;431:4-11 31.
Garg A. Insulin Resistance in the Pathogenesis of Dyslipidemia. Diabetes Care.1996;194:387-389
32. Kolovou GD, Anagnostopoulou KK, Cokkinos DV. Pathophysiology of
Dyslipidaemia in the Metabolic Syndrome. Postgrad Med J.2005;810:358- 366
33. National Institutes of Healt NIH. ATP III Guidelines At-A-Glance Quick
Desk Reference:2001 34.
Recommendations for the diagnosis and treatment of dyslipidemia. Can J Cardiol.2009;2211:1-5
35. Jellinger PS, Smith DA, Mehta AE, Ganda O, Handelsman Y, Rodbard HW,
etal. American Association of Clinical Endrocrinologists Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis. AACE Lipid
and Atherosclerosis Guidelines, Endocr Pract..2012;180:1-78 36.
Gaggini M, Morelli M, Buzzigoli E, DeFronzo RA, Bugianesi E, Gastaldelli A. Non-Alcoholic Fatty Liver Disease NAFLD and Its Connection with
Insulin Resistance, Dyslipidemia, Atherosclerosis and Coronary Heart Disease. Nutrients.2013;50:1544-1560
37. Souza MRDA, Diniz MDFFDM, Medeiros-Filho JEMD, Araujo MSTD .
Metabolic Syndrome and Risk Factors for Non-Alcoholic Fatty Liver Disease. jan. Imar..2012;491:89-96